DIEBOLD NIXDORF, Inc (DBD) research
DIEBOLD NIXDORF, Inc- Sector
- Technology
- Last price
- $63.37
- As of
DIEBOLD NIXDORF, Inc (DBD): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-07-29.
As of . Source: SEC EDGAR filings for DBD. Method and limitations.
Share the DBD intelligence card
See DBD live in the terminal
Track DBD's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live DBD terminal, freeActive signals for DBD
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 90% of DBD (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 96% of DBD (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 64% of DBD (2026Q2)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 90% of DBD (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 64% of DBD (2026Q2)
FREE, NO ACCOUNT
Every signal on DBD, as it fires
You are seeing 5 of 16 signals recorded on DBD since 2026-06-10.
The five above all landed on 2026-09-06. The other 11 were recorded on 3 other days. 12 of the 16 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in DBD (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| D. E. Shaw & Co., Inc.CUSIP 253651202 · 2026Q2 | $15.6M | 0.01% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 253651202 · 2026Q2 | $4.5M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 253651202 · 2026Q2 | $3.3M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 253651202 · 2026Q2 | $832K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 253651202 · 2026Q2 | $231K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, DBD
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
DBD against its peers
DBD's operating margin of 6.4% ranks in the 60th percentile of 23 Technology sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.
| Metric | DBD | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 3.8B USD | 779M USD | 90 | 24 |
| Gross margin | 25.3% | 70.7% | 8 | 19 |
| Operating margin | 6.4% | 3.8% | 60 | 23 |
| Net margin | 2.5% | 3.5% | 42 | 24 |
| Return on equity | 8.6% | 6.8% | 63 | 22 |
| P / E | 24.9x | 28.2x | 50 | 14 |
Peers (24): NN, ASAN, RAMP, FIVN, BLKB, APPN, AMPL, DXC, TDC, ALRM, PGY, AI, BL, INTA, AVPT, PONY, SPSC, FRSH, EFOR, QTWO, CLSK, RDWR, FSLY, TENB. Left out: LSPD (period gap). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (DBD: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more DBD signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to DBDand get the insider, 13F, options, and confluence read in one view.